Company Overview of Dr. Falk Pharma GmbH
Dr. Falk Pharma GmbH develops and sells medications for indications in hepatology and gastroenterology. The company provides medications for inflammatory bowel diseases, diverticular diseases, constipation/irritable bowel syndrome, disorders of lipid metabolism, and liver diseases, as well as for colon cleansing prior to colonoscopies. It sells its prescription drugs through local partners and subsidiary companies in Germany and internationally. Dr. Falk Pharma GmbH was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. The company was founded in 1960 and is based in Freiburg, Germany.
Founded in 1960
49 761 1514 0
49 761 1514 321
Key Executives for Dr. Falk Pharma GmbH
Similar Private Companies By Industry
|3B Pharmaceuticals GmbH||Europe|
|Accelsiors Group International||Europe|
|Aenova Group GmbH||Europe|
|Aenova Holding GmbH||Europe|
|AiCuris GmbH & Co. KG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Dr. Falk Pharma GmbH, please visit www.drfalkpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.